DE3853422D1 - HIV-3-Retrovirus und seine Verwendung. - Google Patents
HIV-3-Retrovirus und seine Verwendung.Info
- Publication number
- DE3853422D1 DE3853422D1 DE3853422T DE3853422T DE3853422D1 DE 3853422 D1 DE3853422 D1 DE 3853422D1 DE 3853422 T DE3853422 T DE 3853422T DE 3853422 T DE3853422 T DE 3853422T DE 3853422 D1 DE3853422 D1 DE 3853422D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- retrovirus
- nucleic acid
- acid sequence
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010020164 HIV infection CDC Group III Diseases 0.000 title abstract 6
- 241001430294 unidentified retrovirus Species 0.000 title abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88109200A EP0345375B1 (de) | 1988-06-09 | 1988-06-09 | HIV-3-Retrovirus und seine Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3853422D1 true DE3853422D1 (de) | 1995-04-27 |
DE3853422T2 DE3853422T2 (de) | 1995-10-26 |
Family
ID=8199044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3853422T Expired - Lifetime DE3853422T2 (de) | 1988-06-09 | 1988-06-09 | HIV-3-Retrovirus und seine Verwendung. |
Country Status (10)
Country | Link |
---|---|
US (7) | US5304466A (de) |
EP (3) | EP0345375B1 (de) |
JP (1) | JP2882654B2 (de) |
AT (1) | ATE120234T1 (de) |
AU (1) | AU625970B2 (de) |
CY (1) | CY2051B1 (de) |
DE (1) | DE3853422T2 (de) |
DK (1) | DK176078B1 (de) |
ES (1) | ES2072853T3 (de) |
WO (1) | WO1989012094A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364933A (en) * | 1986-03-03 | 1994-11-15 | Institut Pasteur | Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) |
DE3853422T2 (de) * | 1988-06-09 | 1995-10-26 | Innogenetics Nv | HIV-3-Retrovirus und seine Verwendung. |
EP0494317B2 (de) * | 1990-06-15 | 2000-12-27 | Innogenetics N.V. | SIV cpz-ant Retrovirus und seine Anwendungen |
JP3443809B2 (ja) | 1992-03-06 | 2003-09-08 | エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム | 免疫学的に重要なエピトープに相当するペプチドの決定方法、及び免疫学的に重要なエピトープに相当するビオチニル化ペプチド又は抗体の決定のための方法におけるその利用、その調製方法及びそれを含む組成物 |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
ES2126620T5 (es) * | 1992-10-06 | 2010-05-21 | Siemens Healthcare Diagnostics Products Gmbh | Retrovirus del grupo de los vih y su utilizacion. |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
GB9410044D0 (en) * | 1994-05-19 | 1994-07-06 | Int Murex Tech Corp | Assay |
PT787191E (pt) | 1994-10-20 | 2007-12-06 | Pasteur Institut | Sequências nucleotídicas de antigénios retroviraisde vih do tipo (ou sub-tipo) o |
US5599662A (en) * | 1995-02-17 | 1997-02-04 | Hoffmann-La Roche Inc. | Oliconucleotide primers and probes for the detection of HIV-1 |
ES2220982T3 (es) * | 1995-06-07 | 2004-12-16 | Abbott Laboratories | Peptidos destinados a la deteccion del vih-1. |
US5612473A (en) * | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
WO1998040744A1 (de) † | 1997-03-10 | 1998-09-17 | Roche Diagnostics Gmbh | Verfahren zur simultanen bestimmung von hiv-antigenen und hiv-antikörpern |
US6846905B2 (en) * | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
US5922533A (en) * | 1997-08-15 | 1999-07-13 | Abbott Laboratories | Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups |
US7244570B2 (en) | 1998-08-04 | 2007-07-17 | Luminex Molecular Diagnostics, Inc. | Methods and compositions for modulating “marginally indiscriminant” hybridizations |
US6235479B1 (en) | 1999-04-13 | 2001-05-22 | Bio Merieux, Inc. | Methods and devices for performing analysis of a nucleic acid sample |
WO2001004361A2 (en) * | 1999-07-09 | 2001-01-18 | Gen-Probe Incorporated | Detection of hiv-1 by nucleic acid amplification |
CA2391560A1 (en) | 1999-11-16 | 2001-05-25 | Geneart Gmbh Gessellschaft Fur Angewandte Biotechnologie | The genome of the hiv-1 inter-subtype (c/b') and use thereof |
US6582920B2 (en) | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
US6818392B2 (en) | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
US20030175950A1 (en) * | 2001-05-29 | 2003-09-18 | Mcswiggen James A. | RNA interference mediated inhibition of HIV gene expression using short interfering RNA |
WO2003098215A1 (en) * | 2002-05-16 | 2003-11-27 | Medmira Inc. | Rapid vaccinia antibody detection device, method and test kit |
US7611712B2 (en) * | 2003-10-23 | 2009-11-03 | Nelson M. Karp | Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide |
ES2393041T3 (es) * | 2007-10-22 | 2012-12-18 | Amorphical Ltd. | Carbonato de calcio amorfo estable que comprende aminoácidos fosforilados |
EP2550362B1 (de) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv-glycoproteine und rekombinante vektoren |
EP2691530B1 (de) | 2011-06-10 | 2018-03-07 | Oregon Health & Science University | Cmv-glycoproteine und rekombinante vektoren |
EP2568289A3 (de) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
CN107921060A (zh) | 2015-06-04 | 2018-04-17 | 艾玛菲克有限公司 | 用于吸入施用、舌下施用或含服施用的无定形碳酸钙的组合物 |
JP7152785B2 (ja) | 2016-10-25 | 2022-10-13 | アモーフィカル リミテッド. | 白血病治療のための非晶質炭酸カルシウム |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217861A (en) * | 1983-09-15 | 1993-06-08 | Institut Pasteur | Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor |
ES8705522A1 (es) * | 1984-10-18 | 1987-05-01 | Pasteur Institut | Un procedimiento para la preparacion de derivados purificados de una glicoproteina. |
US5066782A (en) * | 1986-01-22 | 1991-11-19 | Institut Pasteur | Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
WO1987004459A1 (fr) * | 1986-01-22 | 1987-07-30 | Institut Pasteur | Retrovirus du type hiv-2 susceptible de provoquer le sida, et ses constituants antigeniques et nucleiques |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
SE8701765L (sv) * | 1987-04-28 | 1988-10-29 | Statens Bakteriologiska Lab | Analysmetod och medel foer denna |
DE3853422T2 (de) * | 1988-06-09 | 1995-10-26 | Innogenetics Nv | HIV-3-Retrovirus und seine Verwendung. |
-
1988
- 1988-06-09 DE DE3853422T patent/DE3853422T2/de not_active Expired - Lifetime
- 1988-06-09 ES ES88109200T patent/ES2072853T3/es not_active Expired - Lifetime
- 1988-06-09 EP EP88109200A patent/EP0345375B1/de not_active Expired - Lifetime
- 1988-06-09 EP EP94110658A patent/EP0657532B1/de not_active Revoked
- 1988-06-09 AT AT88109200T patent/ATE120234T1/de not_active IP Right Cessation
- 1988-06-09 EP EP03008364A patent/EP1369427A3/de not_active Withdrawn
-
1989
- 1989-06-08 JP JP1506144A patent/JP2882654B2/ja not_active Expired - Lifetime
- 1989-06-08 AU AU37628/89A patent/AU625970B2/en not_active Expired
- 1989-06-08 US US07/460,913 patent/US5304466A/en not_active Expired - Lifetime
- 1989-06-08 WO PCT/EP1989/000643 patent/WO1989012094A1/en unknown
-
1990
- 1990-02-08 DK DK199000331A patent/DK176078B1/da not_active IP Right Cessation
-
1994
- 1994-04-15 US US08/228,519 patent/US5567603A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/474,360 patent/US5858647A/en not_active Expired - Lifetime
- 1995-06-07 US US08/486,836 patent/US5795743A/en not_active Expired - Lifetime
-
1997
- 1997-07-25 US US08/900,902 patent/US6013484A/en not_active Expired - Lifetime
-
1998
- 1998-04-30 CY CY9802051A patent/CY2051B1/xx unknown
-
1999
- 1999-08-23 US US09/379,270 patent/US6265200B1/en not_active Expired - Fee Related
-
2001
- 2001-05-09 US US09/851,664 patent/US20030039954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK33190A (da) | 1990-03-28 |
DE3853422T2 (de) | 1995-10-26 |
AU3762889A (en) | 1990-01-05 |
US5795743A (en) | 1998-08-18 |
JPH02504583A (ja) | 1990-12-27 |
US20030039954A1 (en) | 2003-02-27 |
US6265200B1 (en) | 2001-07-24 |
EP0657532B1 (de) | 2003-12-17 |
EP0345375A1 (de) | 1989-12-13 |
EP0345375B1 (de) | 1995-03-22 |
EP1369427A3 (de) | 2004-05-12 |
DK176078B1 (da) | 2006-04-10 |
CY2051B1 (en) | 1998-04-30 |
US5304466A (en) | 1994-04-19 |
AU625970B2 (en) | 1992-07-23 |
EP1369427A2 (de) | 2003-12-10 |
EP0657532A1 (de) | 1995-06-14 |
DK33190D0 (da) | 1990-02-08 |
ES2072853T3 (es) | 1995-08-01 |
WO1989012094A1 (en) | 1989-12-14 |
US6013484A (en) | 2000-01-11 |
US5567603A (en) | 1996-10-22 |
US5858647A (en) | 1999-01-12 |
JP2882654B2 (ja) | 1999-04-12 |
ATE120234T1 (de) | 1995-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE120234T1 (de) | Hiv-3-retrovirus und seine verwendung. | |
Cafaro et al. | Control of SHIV-89.6 P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine | |
Salminen et al. | Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C | |
CA2009403C (en) | A packaging defective hiv provirus, cell lines, and uses thereof | |
NO921969L (no) | Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener | |
DE69535757D1 (de) | Rekombinanter immunschwächepoxvirus | |
NO874750L (no) | Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater. | |
ES2099066T3 (es) | Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1). | |
CA2107732A1 (en) | Retrovirus from the hiv group and its use | |
EP0512017A1 (de) | Vakzine. | |
ATE362379T1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
EP0608261A4 (de) | Zusammensetzung aus einem immunreaktiven hepatitis-c-virus-polypeptid. | |
KR950032278A (ko) | 사람 면역결핍 바이러스 그룹의 레트로바이러스로부터 유래된 펩타이드 및 이의 용도 | |
DE60026199T2 (de) | Synthetische Gene für gagpol und deren Verwendungen | |
EP0342860A3 (de) | Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung | |
DE3855134T2 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
Etemad-Moghadam et al. | Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys | |
EP0242216A1 (de) | Nicht cytopathischer Klon von menschlichem T-Zellen lymphotropen Virus Typ-III | |
Hourioux et al. | Identification of the Glycoprotein 41™ Cytoplasmic Tail Domains of Human Immunodeficiency Virus Type 1 That Interact with Pr55Gag Particles | |
DK0480949T3 (da) | Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse | |
US20070172930A1 (en) | process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof | |
Hejdeman et al. | DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy | |
Bibollet-Ruche et al. | Complete genome analysis of one of the earliest SIVcpz Ptt strains from Gabon (SIVcpzGAB2) | |
EP0315459A2 (de) | Umvollständige HIV-Partikel und Verfahren zu ihrer Herstellung | |
CA2408786A1 (en) | Retroviral vectors comprising an enhanced 3' transcription termination structure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |